Senior Scientist, B Cell Immunology & Antibody Discovery

Prellis Biologics, Inc; Berkeley (CA); Hybrid; USD 120,000 - 190,000; Full time

Benefits offered by this job

Stock-based long-term incentives

Holiday package

Flexible work models

Job summary

Prellis Biologics seeks a Scientist – B Cell Biology & Immunology to advance its in vitro immune system platform and lymph node organoid technologies for antibody discovery. The role emphasizes primary immune-cell culture, flow cytometry, and functional assay development, within a fast-paced startup environment.

The successful candidate will lead experimental design, execution, data analysis, and method development to support therapeutic antibody discovery and ex vivo immunization strategies at

Qualifications

• Ph.D. in Immunology or related field.
• 5+ years of lab experience in immunology/cell biology; industry preferred.
• Strong background in B-cell biology and antibody discovery.
• Experience with primary immune-cell isolation, culture, and in vitro stimulation.
• Hands-on flow cytometry with panel design, staining, and sorting.

Responsibilities

• Design, execute, and optimize complex cell-based experiments.
• Develop in vitro immune-cell culture and stimulation strategies.
• Spend 60–80% of time at bench performing experiments.
• Troubleshoot protocols and improve workflows.
• Analyze immunological data and donor-related panels for ex vivo immunization.

Skills

B cell biology

antibody discovery

primary immune-cell culture

flow cytometry

experimental design

data analysis

Education

Ph.D. in Immunology

Tools

FlowJo

GraphPad Prism

Job description

Prellis Biologics seeks a Scientist – B Cell Biology & Immunology to advance its in vitro immune system platform and lymph node organoid technologies for antibody discovery. The role emphasizes primary immune-cell culture, flow cytometry, and functional assay development, within a fast-paced startup environment.

The successful candidate will lead experimental design, execution, data analysis, and method development to support therapeutic antibody discovery and ex vivo immunization strategies at